Pattern of failure and clinical value of local therapy for oligo‐recurrence in locally advanced non‐small cell lung cancer after definitive chemoradiation: Impact of driver mutation status
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5493
Abstract: Considerable differences of treatment response and pattern of failure may exist between definitive chemoradiation (CRT) treated locally advanced non‐small cell lung cancer (LA‐NSCLC) patients. The clinical value of additional tyrosine kinase inhibitors (TKIs) before disease… read more here.
Keywords: locally advanced; definitive chemoradiation; cancer; non small ... See more keywords
Supraclavicular node disease is not an independent prognostic factor for survival of esophageal cancer patients treated with definitive chemoradiation
Sign Up to like & getrecommendations! Published in 2017 at "Acta Oncologica"
DOI: 10.1080/0284186x.2016.1240880
Abstract: Abstract Background: The prognostic value of supraclavicular lymph node (SCN) metastases in esophageal cancer is not well established. We analyzed the prognostic value of SCN disease in patients after definitive chemoradiation (dCRT) for esophageal cancer.… read more here.
Keywords: esophageal cancer; patients treated; disease; scn ... See more keywords
Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation.
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Surgery"
DOI: 10.1097/sla.0000000000003228
Abstract: MINI: Low continuous total lesion glycolysis value, but not low maximum standardized uptake value, was associated with cure (odds ratio 0.70, 95% confidence interval 0.54-0.92) in patients with localized esophageal adenocarcinoma who received definitive chemoradiation.… read more here.
Keywords: total lesion; lesion glycolysis; definitive chemoradiation; chemoradiation ... See more keywords
Statewide rates of adjuvant checkpoint inhibitor use after definitive chemoradiation for stage III non-small cell lung cancer.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.8523
Abstract: 8523 Background: In the landmark PACIFIC trial, adjuvant durvalumab after definitive chemoradiation for unresectable stage III non-small-cell lung cancer (NSCLC) produced a 11% absolute overall survival benefit at two years compared to placebo, and the… read more here.
Keywords: ici ici; stage iii; definitive chemoradiation; ici ... See more keywords
Demographic disparities in delay of definitive chemoradiation for anal squamous cell carcinoma: a nationwide analysis.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of gastrointestinal oncology"
DOI: 10.21037/jgo.2018.08.07
Abstract: Background Prolonged time to treatment initiation (TTI) for patients with curable anal cancer may reduce tumor control. This study investigated demographic disparities in TTI for patients receiving definitive chemoradiation (CRT) for anal squamous cell carcinoma… read more here.
Keywords: demographic disparities; anal squamous; cell carcinoma; squamous cell ... See more keywords
A Pilot Study Examining the Prognostic Utility of Tumor Shrinkage on Cone-Beam Computed Tomography (CBCT) for Stage III Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Definitive Chemoradiation
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Environmental Research and Public Health"
DOI: 10.3390/ijerph18063241
Abstract: There has been growing interest in utilizing information from cone-beam computed tomography (CBCT) to help guide both treatment delivery and prognosis. In this assessment of locally advanced unresectable stage III non-small cell lung cancer (NSCLC)… read more here.
Keywords: stage iii; tumor volume; shrinkage; chemoradiation ... See more keywords